NM_000277.3:c.510-20_510-18dupATT
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_000277.3(PAH):c.510-20_510-18dupATT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000567 in 1,612,404 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000277.3 intron
Scores
Clinical Significance
Conservation
Publications
- phenylketonuriaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
- classic phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- maternal phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild hyperphenylalaninemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PAH | NM_000277.3 | c.510-20_510-18dupATT | intron_variant | Intron 5 of 12 | ENST00000553106.6 | NP_000268.1 | ||
| PAH | NM_001354304.2 | c.510-20_510-18dupATT | intron_variant | Intron 6 of 13 | NP_001341233.1 | |||
| PAH | XM_017019370.2 | c.510-20_510-18dupATT | intron_variant | Intron 5 of 6 | XP_016874859.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PAH | ENST00000553106.6 | c.510-18_510-17insATT | intron_variant | Intron 5 of 12 | 1 | NM_000277.3 | ENSP00000448059.1 | |||
| PAH | ENST00000549111.5 | n.606-18_606-17insATT | intron_variant | Intron 5 of 5 | 1 | |||||
| PAH | ENST00000307000.7 | c.495-18_495-17insATT | intron_variant | Intron 6 of 13 | 5 | ENSP00000303500.2 | ||||
| PAH | ENST00000551988.5 | n.531-18_531-17insATT | intron_variant | Intron 4 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00288 AC: 439AN: 152186Hom.: 3 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000791 AC: 198AN: 250414 AF XY: 0.000591 show subpopulations
GnomAD4 exome AF: 0.000315 AC: 460AN: 1460100Hom.: 4 Cov.: 33 AF XY: 0.000286 AC XY: 208AN XY: 726514 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00298 AC: 454AN: 152304Hom.: 4 Cov.: 33 AF XY: 0.00312 AC XY: 232AN XY: 74462 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
- -
Variant summary: PAH c.510-20_510-18dupATT alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. The variant allele was found at a frequency of 0.0011 in 281816 control chromosomes, predominantly at a frequency of 0.011 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 1.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in PAH causing Phenylalanine Hydroxylase Deficiency (Phenylketonuria) phenotype (0.0079), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.510-20_510-18dupATT in individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Phenylketonuria Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at